Role of angiotensin in cardioprotective effect of ischemic preconditioning

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 5, 1999, Pages 772-778

  Sharma, Ajay ^a   Singh, Manjeet ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Angiotensin; CV 11974; Ischemic preconditioning; PD 123319

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN; CREATINE KINASE; LACTATE DEHYDROGENASE; TRIPHENYLTETRAZOLIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; REGIONAL PERFUSION; REPERFUSION INJURY;

ANGIOTENSIN II; ANIMALS; BENZIMIDAZOLES; CORONARY CIRCULATION; CREATINE KINASE; FEMALE; HEART RATE; IMIDAZOLES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0032920584     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199905000-00014     Document Type: Article

References (30)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 1986;74:1124-36.
2. Li Y, Whittaker P, Kloner RA. The transient nature of the effect of ischaemic preconditioning on myocardial infarct size and ventricular arrhythmias. Am Heart J 1992;123:346-53.
3. Weselchouch EO, Braid AJ, Sleph PG, Dzwonczyk S, Murray NH, Grover GJ. Endogenous catecholamines are not necessary for ischaemic preconditioning in isolated perfused rat heart. Cardiovasc Res 1995;29:126-32.
4. 1B adrenoceptors, pertussis toxin-sensitive G proteins and protein kinase C. Circulation 1995;92:2259-65.
5. 1-adrenergic signal transduction pathway or protein kinase C in isolated rat heart. Cardiovasc Drug Ther 1996;10:125-36.
6. Shultz JEJ, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischaemic preconditioning. Am J Physiol 1995; 29:682-8.
7. Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 1995;27: 883-92.
8. Thomas GP, Ferries GR, Howlett SE. Losartan exerts antiarrhythmic activity independent of angiotensin II receptor blockade in simulated ventricular ischaemia and reperfusion. J Pharmacol Exp Ther 1996;278:1090-7.
9. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterisation of angiotensin II receptor subtypes in rat heart. Circ Res 1992;71:1482-9.
10. Suzuki J, Matsubarara H, Urakami M, Inada M. Rat angiotensin II (type IA) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 1993;73:439-47.
11. Rogg H, Schmid A, deGasparo M. Identification and characterisation of angiotensin II receptor subtypes in rabbit ventricular myocardium. Biochem Biophys Res Commun 1990;173:416-22.
12. Scott AL, Chong RSL, Lotti VJ, Siegl PKS. Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists DuP 753 and PD 121981 in rabbit heart. J Pharmacol Exp Ther 1992; 261:931-5.
13. Dzau VJ. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 1987;59: 59A-65A.
14. Ertl G, Alexander RW, Kloner RA. Interactions between coronary occlusion and the renin-angiotensin system in the dog. Basic Res Cardiol 1983;78:518-33.
15. Langendorff O. Untersuchungen am uberlebender saugethierherzen. Pflugers Arch 1895;61:291-332.
16. Hughes BP. A method for the estimation of serum creatine kinase and aldose activity in the normal and pathological sera. Clin Chim Acta 1961;7:597-603.
17. King J. A routine method for the estimation of lactic dehydrogenase activity. J Med Lab Tech 1959;16:265-72.
18. Fishbein MC, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J 1981;101:593-600.
19. Chopra K, Singh M, Kaul N, Andrabi KI, Ganguly NK. Decrease of myocardial infarct size with desferrioxamine: possible role of oxygen free radicals in its ameliorative effect. Mol Cell Biochem 1992;113:71-6.
20. Parikh V, Singh M. Resident cardiac mast cells and cardioprotective effect of ischaemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol 1997;30:149-56.
21. Parikh V, Singh M. Cardiac mast cell stabilisation and cardioprotective effect of ischaemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol 1998;31:779-85.
22. + exchange inhibitor, on cardioprotective effect of ischaemic preconditioning: possible involvement of resident cardiac mast cells. Pharmacol Res 1997;36:95-102.
23. Fralix TA, Steenbergen C, London RE, Murphy E. Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart. Cardiovasc Res 1993;27: 630-7.
24. Grover GJ, Dzwonczyk S, Sleph PG, Sergent COR. The ATP sensitive potassium channel blocker glibenclamide (Glyburide) does not abolish preconditioning in isolated ischaemic rat heart. J Pharmacol Exp Ther 1993;256:559-65.
25. 2) receptor is linked to protein kinase C but not to c-AMP dependent pathways in the cardiomyocyte. Can J Physiol Pharmacol 1996;74:125-31.
26. Randall MD, Gardiner SM, Bennett T. Enhanced cardiac preconditioning in the isolated heart of the transgenic [(mRen-2)27] hypertensive rat. Cardiovasc Res 1997;33:400-9.
27. 1 angiotensin II receptors abolishes ischaemic preconditioning in isolated rabbit hearts. J Mol Cell Cordiol 1997;29:129-39.
28. 125I]IBE 2254. J Mol Cell Cardiol 1982;14:601-10.
29. Schwarz ER, Montino H, Fleischhauer J, Klues HG, Dahl J, Hanrath P. Angiotensin II receptor antagonist EXP 3174 reduces infarct size comparable with enalaprilat and augments preconditioning in the pig heart. Cardiovasc Drugs Ther 1997;11:687-95.
30. Kubo A, Fukuda N, Soma M, Izumi Y, Kanmatsuse K. Inhibitory effect of an angiotensin II type 1 receptor antagonist on growth of vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 1996;27:58-63.